594 filings
424B3
PRTG
Portage Biotech Inc
8 Mar 24
Prospectus supplement
5:30pm
6-K
PRTG
Portage Biotech Inc
8 Mar 24
Current report (foreign)
5:04pm
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
6-K
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
6-K
PRTG
Portage Biotech Inc
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
6-K
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
SC 13G
Armistice Capital, LLC
14 Feb 24
PORTAGE BIOTECH / ARMISTICE CAPITAL ownership change
3:50pm
424B3
PRTG
Portage Biotech Inc
18 Jan 24
Prospectus supplement
5:41pm
6-K
PRTG
Portage Biotech Inc
18 Jan 24
Current report (foreign)
5:09pm
424B3
PRTG
Portage Biotech Inc
4 Jan 24
Prospectus supplement
5:49pm
6-K
PRTG
Portage Biotech Inc
4 Jan 24
Current report (foreign)
8:10am
S-8
PRTG
Portage Biotech Inc
1 Dec 23
Registration of securities for employees
4:05pm
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
6-K
PRTG
Portage Biotech Inc
28 Nov 23
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
4:02pm
6-K
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
424B3
PRTG
Portage Biotech Inc
14 Nov 23
Prospectus supplement
6:00am
6-K
PRTG
Portage Biotech Inc
13 Nov 23
Current report (foreign)
6:10am
EFFECT
PRTG
Portage Biotech Inc
8 Nov 23
Notice of effectiveness
12:15am
424B3
PRTG
Portage Biotech Inc
7 Nov 23
Prospectus supplement
4:50pm